Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
Simron Singh, Daniel M. Halperin, Sten D. Myrehaug, Ken Herrmann, Marianne Pavel, Pamela L. Kunz and 14 more
- Rank
- 28 of 1,531
- Percentile
- top 1.9%
- Where
- The Lancet, 2024
- Citations
- 401
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.